Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 22 Vitamin D Deficiency 20 Prostatic Neoplasms 17 Polycystic Ovary Syndrome 10 Neoplasms 9 Colonic Neoplasms 8 Rectal Neoplasms 6 Colorectal Neoplasms 6 Osteoporosis 5 Myelodysplastic Syndromes 5 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Cardiovascular Diseases 4 Warts 3 Ovarian Neoplasms 3 Leukemia, Myeloid, Acute 3 Leukemia 3 Brain Neoplasms 3 Adenomatous Polyps 3 Pathologic Processes 2 Pain 2 Obesity 2 Myeloproliferative Disorders 2 Myelodysplastic-Myeloproliferative Diseases 2 Musculoskeletal Diseases 2 Melanoma 2 Male Urogenital Diseases 2 Lymphoma, Non-Hodgkin 2 Lymphoma, Large B-Cell, Diffuse 2 Lymphoma, Follicular 2

Interventions

valrubicin 3 dodecyl maltoside 3 Mitomycin 3 Magnetic Resonance Imaging 3 Gemcitabine 3 durvalumab 2 Interferon beta-1b 2 Electrocardiography 2 Diphenhydramine 2 Cystoscopy 2 Biopsy 2 Acetaminophen 2 toripalimab 1 pembrolizumab 1 fludarabine phosphate 1 fludarabine 1 enfortumab vedotin 1 cemiplimab 1 apaziquone 1 aldesleukin 1 advexin 1 Tomography, X-Ray Computed 1 Surveys and Questionnaires 1 Standard of Care 1 Sampling Studies 1 Respiratory Function Tests 1 Proflavine 1 Prochlorperazine 1 Positron-Emission Tomography 1 Physical Examination 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Carcinoma in Situ × Cholecalciferol × Clear all

NCT02698293 2022-11-22

PDT Plus Vitamin D3 for Anal Dysplasia

Abramson Cancer Center at Penn Medicine

Phase 1 Withdrawn

Carcinoma in Situ

Data powered by HemOnc (CC BY 4.0) Colophon ⚡